$Plus Therapeutics (PSTV.US)$Benzinga· 1 min ago Plus Therapeutics Presented Data In Podium Presentation Updating The Progress Of Its ReSPECT-LM Trial Of Rhenium Obisbemeda In Leptomeningeal Disease At The 2024 Society For NeuroOncology/American Society For Clinical Oncology CNS Metastases Conference
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Trytosaveabit OP : Positive Interim Respect-Lm Phase 1 Data for Leptomeningeal Metastases
joeyboulevard : not in here currently??